Platypus venom could hold key to diabetes treatment
Tuesday, 28 February, 2017
Australian researchers have discovered remarkable evolutionary changes to insulin regulation in the platypus and the echidna 鈥 which could pave the way for new treatments for type 2 diabetes in humans.
The research team, led by Professor Frank Gr眉tzner at the University of Adelaide and Associate Professor Briony Forbes at Flinders University, has discovered these monotremes have evolved changes in the hormone GLP-1 that make them resistant to the rapid degradation normally seen in humans.
In people with type 2 diabetes, the short stimulus triggered by GLP-1 isn鈥檛 sufficient to maintain a proper blood sugar balance. As a result, medication that includes a longer lasting form of the hormone is needed to help provide an extended release of insulin.
鈥淲e鈥檝e discovered conflicting functions of GLP-1 in the platypus: in the gut as a regulator of blood glucose and in venom to fend off other platypus males during breeding season,鈥 said Professor Forbes.
鈥淭he function in venom has most likely triggered the evolution of a stable form of GLP-1 in monotremes,鈥 she said.
$12m for homegrown heart disease and diabetes innovations
$12 million in federal funding has been announced for the development of new Australian-made...
National cancer screening program marks first in almost 20 years
From 1 July, the National Lung Cancer Screening Program will commence — marking the first...
Doctor deregistered after botched facelift calls for ambulance
A Queensland doctor has been deregistered after a botched cosmetic surgery procedure left a...